Indiana Attorney General Greg Zoeller’s office filed a licensing complaint today against the Massachusetts-based pharmacy linked to the meningitis outbreak.

“This pharmacy failed to ensure its epidural steroid injections were safe for patients which led to devastating harm,” Zoeller said. “This formal licensing complaint against the New England Compounding Center will soon be considered by the Indiana Board of Pharmacy which has the authority to determine the appropriate discipline.” 

Zoeller added the board will consider the formal complaint at its next meeting on Feb. 11th. 

As of Dec. 12, the CDC identified six deaths and 63 total cases of fungal meningitis in Indiana stemming from epidural steroid injections produced by the New England Compounding Center.

According to the complaint, nationwide there were a total of 568 cases and 37 deaths across 19 states.